Philippines - English - FDA (Food And Drug Administration)

roche (philippines) inc.; distributor: roche (philippines) inc. - baloxavir marboxil - film-coated tablet - 20 mg

Philippines - English - FDA (Food And Drug Administration)

f. hoffman- la roche ltd.; importer: roche (philippines) inc.; distributor: roche (philippines) inc. - baloxavir marboxil - tablet - 40 mg

United States - English - NLM (National Library of Medicine)

apotex corp. - doripenem (unii: bhv525jobh) (doripenem - unii:bhv525jobh) - doripenem 250 mg in 10 ml - doripenem for injection is indicated as a single agent for the treatment of complicated intra-abdominal infections caused by escherichia coli, klebsiella pneumoniae, pseudomonas aeruginosa, bacteroides caccae, bacteroides fragilis, bacteroides thetaiotaomicron, bacteroides uniformis, bacteroides vulgatus, streptococcus intermedius, streptococcus constellatus, and peptostreptococcus micros . doripenem for injection is indicated as a single agent for the treatment of complicated urinary tract infections, including pyelonephritis caused by escherichia coli including cases with concurrent bacteremia, klebsiella pneumoniae , proteus mirabilis , pseudomonas aeruginosa , and acinetobacter baumannii . to reduce the development of drug-resistant bacteria and maintain the effectiveness of doripenem for injection and other antibacterial drugs, doripenem for injection should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility infor

Canada - English - Health Canada

eli lilly canada inc - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists

Canada - English - Health Canada

apotex inc - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists

Canada - English - Health Canada

pharmascience inc - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists

United States - English - NLM (National Library of Medicine)

rebel distributors corp - butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - butalbital 50 mg - dolgic plus is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: - hypersensitivity or intolerance to any component of this product. - patients with porphyria. butalbital: barbiturates may be habit-forming : tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increased; tolerance to a fatal dosage, however, does not increase more than two-fold. as this occurs, the margin between an intoxication dosage and fatal dosage

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

shionogi ltd - ospemifene - tablet - 60mg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

shionogi & co., ltd. - alclometasone dipropionate - pale yellowish white translucent ointment

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

shionogi & co., ltd. - extract of dermatophagoides pteronyssinus; extract of dermatophagoides farinae - white to brownish white tablet with brown spots, diameter: 6.0 mm, thickness: 3.6 mm